Microscopic Polyangiitis [clinicaltrials_resource:ddfac5bd43815b1dd7a0cac48e1a83e6]
clinicaltrials:NCT00104299RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00307593]Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [clinicaltrials:NCT00307671]clinicaltrials:NCT00315393CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors [clinicaltrials:NCT00400075]CellCept in p-ANCA Vasculitis [clinicaltrials:NCT00405860]Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [clinicaltrials:NCT00430105]clinicaltrials:NCT00748644Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00751517]Anti-Cytokine Therapy for Vasculitis [clinicaltrials:NCT00753103]clinicaltrials:NCT01066208One-Time DNA Study for Vasculitis [clinicaltrials:NCT01241305]clinicaltrials:NCT01405807clinicaltrials:NCT01408836Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study [clinicaltrials:NCT01586858]BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis [clinicaltrials:NCT01598857]clinicaltrials:NCT01697267PRO Development for ANCA Associated Vasculitis [clinicaltrials:NCT01729624]clinicaltrials:NCT01731561clinicaltrials:NCT02006134clinicaltrials:NCT02126098clinicaltrials:NCT02169219Reproductive Health in Men and Women With Vasculitis [clinicaltrials:NCT02176070]Vasculitis Illness Perception (VIP) Study [clinicaltrials:NCT02190916]Educational Needs of Patients With Systemic Vasculitis [clinicaltrials:NCT02190929]VCRC Patient Contact Registry Patient-Reported Data Validation Study [clinicaltrials:NCT02190942]clinicaltrials:NCT02198248clinicaltrials:NCT02474888Impact of Vasculitis on Employment and Income [clinicaltrials:NCT02476292]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00103792clinicaltrials:NCT00104299RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00307593]IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis [clinicaltrials:NCT00307645]Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [clinicaltrials:NCT00307671]clinicaltrials:NCT00315393CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors [clinicaltrials:NCT00400075]CellCept in p-ANCA Vasculitis [clinicaltrials:NCT00405860]Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [clinicaltrials:NCT00430105]clinicaltrials:NCT00647166clinicaltrials:NCT00748644Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00751517]Anti-Cytokine Therapy for Vasculitis [clinicaltrials:NCT00753103]clinicaltrials:NCT00987389clinicaltrials:NCT01066208One-Time DNA Study for Vasculitis [clinicaltrials:NCT01241305]clinicaltrials:NCT01405807clinicaltrials:NCT01408836Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study [clinicaltrials:NCT01586858]BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis [clinicaltrials:NCT01598857]An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [clinicaltrials:NCT01613599]clinicaltrials:NCT01663623clinicaltrials:NCT01697267PRO Development for ANCA Associated Vasculitis [clinicaltrials:NCT01729624]clinicaltrials:NCT01731561A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [clinicaltrials:NCT01750697]clinicaltrials:NCT02006134A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis [clinicaltrials:NCT02115997]clinicaltrials:NCT02126098clinicaltrials:NCT02169219Reproductive Health in Men and Women With Vasculitis [clinicaltrials:NCT02176070]Vasculitis Illness Perception (VIP) Study [clinicaltrials:NCT02190916]Educational Needs of Patients With Systemic Vasculitis [clinicaltrials:NCT02190929]VCRC Patient Contact Registry Patient-Reported Data Validation Study [clinicaltrials:NCT02190942]clinicaltrials:NCT02198248clinicaltrials:NCT02474888Impact of Vasculitis on Employment and Income [clinicaltrials:NCT02476292]clinicaltrials:NCT02507024
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00103792clinicaltrials:NCT00104299RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00307593]IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis [clinicaltrials:NCT00307645]Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [clinicaltrials:NCT00307671]clinicaltrials:NCT00315393CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors [clinicaltrials:NCT00400075]CellCept in p-ANCA Vasculitis [clinicaltrials:NCT00405860]Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [clinicaltrials:NCT00430105]clinicaltrials:NCT00647166clinicaltrials:NCT00748644Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00751517]Anti-Cytokine Therapy for Vasculitis [clinicaltrials:NCT00753103]clinicaltrials:NCT00987389clinicaltrials:NCT01066208One-Time DNA Study for Vasculitis [clinicaltrials:NCT01241305]clinicaltrials:NCT01405807clinicaltrials:NCT01408836Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study [clinicaltrials:NCT01586858]BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis [clinicaltrials:NCT01598857]An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [clinicaltrials:NCT01613599]clinicaltrials:NCT01663623clinicaltrials:NCT01697267PRO Development for ANCA Associated Vasculitis [clinicaltrials:NCT01729624]clinicaltrials:NCT01731561A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [clinicaltrials:NCT01750697]clinicaltrials:NCT02006134A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis [clinicaltrials:NCT02115997]clinicaltrials:NCT02126098clinicaltrials:NCT02169219Reproductive Health in Men and Women With Vasculitis [clinicaltrials:NCT02176070]Vasculitis Illness Perception (VIP) Study [clinicaltrials:NCT02190916]Educational Needs of Patients With Systemic Vasculitis [clinicaltrials:NCT02190929]VCRC Patient Contact Registry Patient-Reported Data Validation Study [clinicaltrials:NCT02190942]clinicaltrials:NCT02198248clinicaltrials:NCT02474888Impact of Vasculitis on Employment and Income [clinicaltrials:NCT02476292]clinicaltrials:NCT02507024
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Microscopic Polyangiitis [clinicaltrials_resource:ddfac5bd43815b1dd7a0cac48e1a83e6]
Bio2RDF identifier
ddfac5bd43815b1dd7a0cac48e1a83e6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ddfac5bd43815b1dd7a0cac48e1a83e6
identifier
clinicaltrials_resource:ddfac5bd43815b1dd7a0cac48e1a83e6
title
Microscopic Polyangiitis
@en
type
label
Microscopic Polyangiitis [clinicaltrials_resource:ddfac5bd43815b1dd7a0cac48e1a83e6]
@en
Microscopic Polyangiitis